Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers

Keyphrases

• Food Intake 100%
• Food Body 100%
• Exendin-4 (Ex-4) 100%
• Proopiomelanocortin 50%
• Neuropeptide Y 37%
• Gene Expression 25%
• High-fat Diet 25%
• High-fat Diet Mice 25%
• Arcuate nucleus 25%
• Agouti Gene 25%
• Tyrosine Hydroxylase 25%
• Standard Chow 25%
• Mesolimbic 25%
• Protein-coding Genes 12%
• Receptor Agonist 12%
• Neural Mechanisms 12%
• A1 Receptor 12%
• Sprague-Dawley Rats 12%
• Weight Loss 12%
• Nucleus Accumbens 12%
• Reduced Food Intake 12%
• High-fat Feeding 12%
• Glucagon-like 12%
• Consecutive Days 12%
• Decreased Food Intake 12%
• Repeated Administration 12%
• High Fat Intake 12%
• Dopamine D2 Receptor (DRD2) 12%
• Twice a Day 12%
• Fed Condition 12%
• Treatment Termination 12%
• Dopamine Precursor 12%
• Tyrosine Hydroxylase Expression 12%
• Ventral Tegmental Area 12%
• Hypothalamic Arcuate nucleus 12%
• Dopamine Receptor 1 12%
• Neuropeptide Y Gene 12%

Medicine and Dentistry

• Body Weight 100%
• Food Intake 100%
• Exenatide 100%
• Neuropeptide Y 50%
• Proopiomelanocortin 50%
• Tyrosine 3 Monooxygenase 37%
• Arcuate Nucleus 37%
• High Fat Food 37%
• Gene Expression 25%
• Fat Intake 25%
• Agouti Related Protein 25%
• Precursor 12%
• Rebound 12%
• Ventral Tegmental Area 12%
• Dopamine 1 Receptor 12%
• Glucagon-Like Peptide-1 Agonist 12%
• Repeated Drug Dose 12%
• Nucleus Accumbens 12%
• Dopamine Receptor D2 12%

Neuroscience

• Exenatide 100%
• Neuropeptide Y 50%
• Proopiomelanocortin 50%
• Arcuate Nucleus 37%
• Tyrosine Hydroxylase 37%
• Gene Expression 25%
• Agouti Gene 25%
• Nucleus Accumbens 12%
• Dopamine Receptor D1 12%
• Dopamine Receptor D2 12%
• Glucagon-Like Peptide-1 Agonist 12%
• Ventral Tegmental Area 12%